ADVERTISEMENT

Share Market Outlook 2022 - A Year Of Heightened Activity: Motilal Oswal

Taking Stock I 2021 - A Year Of Heightened Activity: Motilal Oswal

<div class="paragraphs"><p>An employee pushes a cart between aisles of merchandise while collecting items for customer delivery. (Photographer Alex Kraus/Bloomberg)</p></div>
An employee pushes a cart between aisles of merchandise while collecting items for customer delivery. (Photographer Alex Kraus/Bloomberg)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

CY21 was a year of heightened activity on multiple fronts. The year began with a hope as the country put behind the Covid-19 first wave, only to encounter a much more severe second wave in March-May 2021.

Subsequently, as the wave ebbed, the economy and markets saw good recovery as India’s Covid-19 vaccination began gradually and acquired momentum along the way to end CY21 with mammoth ~1.45 billion vaccine doses administered during the year.

CY21 witnessed record activity in primary markets with highest ever fund-raise and debut of several new-age digital tech businesses on the bourses. Corporate earnings continued to build on the FY21 momentum and looks set for another strong year of earnings.

While the year witnessed several disruptions on global supply chain front with shortages of chips and ships, the macro conversations were dominated by inflation raising its head globally and consequent Fed action with the much debated Taper finally making its presence felt.

As we usher into CY22 with the third wave of Covid-19 knocking at the doors, we take a look back at the year gone by and some of the key highlights pertaining to the same.

Click on the attachment to read the full report:

Motilal Oswal India Strategy.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.